{
  "retracted": false,
  "timestamp": 1504224000000,
  "updates": [
    {
      "timestamp": 1585462737705,
      "identifier": {
        "doi": "10.1161/jaha.117.002231"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1161/jaha.116.004382"
  },
  "publisher": "Ovid Technologies (Wolters Kluwer Health)",
  "title": "Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction"
}
